Deep Track Capital’s HOOKIPA Pharma HOOK Stock Holding History

Deep Track Capital’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-124,037	Closed	-$1M	–	68
2022 Q4	$1M	Sell	124,037 -379,563	-75%	-$4.11M	0.04%	59
2022 Q3	$6.75M	Hold	503,600	–	–	0.31%	59
2022 Q2	$8.21M	Hold	503,600	–	–	0.54%	39
2022 Q1	$11.5M	Buy	+503,600	New	+$9.03M	0.74%	36

Other funds holding HOOK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Deep Track Capital's HOOK Position: Q1 2023 in Review

Deep Track Capital sold out of HOOKIPA Pharma (HOOK) in Q1 2023, closing a stake of 124,037 shares — an estimated $1M sold.

Deep Track Capital first reported a position in HOOK in Q1 2022 and held it in 4 quarters. The position peaked at $11.5M in Q1 2022. 45 funds tracked by Wall St. Rank hold HOOK as of Q1 2023.

Deep Track Capital reported no remaining HOOKIPA Pharma position as of Q1 2023 after selling out during the quarter.
Deep Track Capital sold 124,037 HOOKIPA Pharma shares in Q1 2023, an estimated $1M.
Deep Track Capital first reported a position in HOOKIPA Pharma in Q1 2022 and held it in 4 quarters.
Deep Track Capital's HOOKIPA Pharma position peaked at $11.5M in Q1 2022.
45 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q1 2023.

Based on Deep Track Capital's 13F filing for Q1 2023, filed 15 May 2023.